Lysozyme: A Natural Product with Multiple and Useful Antiviral Properties

Author:

Bergamo Alberta1,Sava Gianni1ORCID

Affiliation:

1. Department of Life Sciences, University of Trieste, 34127 Trieste, Italy

Abstract

Lysozyme, especially the one obtained from hen’s egg white, continues to show new pharmacological properties. The fact that only a few of these properties can be translated into therapeutic applications is due to the lack of suitable clinical studies. However, this lack cannot hide the evidence that is emerging from scientific research. This review for the first time examines, from a pharmacological point of view, all the relevant studies on the antiviral properties of lysozyme, analyzing its possible mechanism of action and its ability to block viral infections and, in some cases, inhibit viral replication. Lysozyme can interact with nucleic acids and alter their function, but this effect is uncoupled from the catalytic activity that determines its antibacterial activity; it is present in intact lysozyme but is equally potent in a heat-degraded lysozyme or in a nonapeptide isolated by proteolytic digestion. An analysis of the literature shows that lysozyme can be used both as a disinfectant for raw and processed foods and as a drug to combat viral infections in animals and humans. To summarize, it can be said that lysozyme has important antiviral properties, as already suspected in the initial studies conducted over 50 years ago, and it should be explored in suitable clinical studies on humans.

Publisher

MDPI AG

Subject

Chemistry (miscellaneous),Analytical Chemistry,Organic Chemistry,Physical and Theoretical Chemistry,Molecular Medicine,Drug Discovery,Pharmaceutical Science

Reference82 articles.

1. Lysozymes in the animal kingdom;Callewaert;J. Biosci.,2010

2. Human lysozyme (origin and distribution in health and disease);Reitamo;Ric. Clin. Lab.,1978

3. What’s new in lysozyme research? Always a model system, today as yesterday;Mol. Cell. Biochem.,1984

4. Shteyngart, B. (2005). Intratracheal Administration of Lysozyme with Other Therapeutic Agents in the Prevention and Treatment of Respiratory Disorders. (US20050271645), U.S. Patent.

5. Kiaerulff, S., Cohn, M.T., and Kristensen, N.N. (2018). Microbial Lysozyme for Use in the Treatment of Irritable Bowel Syndrome or Inflammatory Bowel Disease. (WO2018127532), U.S. Patent.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3